€0.27 0.0 0.0%
Last Trade - 31/03/17
| Market Cap | ÂŁn/a |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁn/a |
| Position in Universe | th / 1046 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 01st Jan | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Bioenergy Capital AG is a Germany-based investment company that invests in companies from the areas of health care, medicine, nutrition and cosmetics. The Company holds interest in Vitis Traubenkern GmbH and Bioenergy Healthcare GmbH. Vitis Traubenkern GmbH offers natural grape seed products, such as grape seed oil, flavored oils, grape seed flour, grape seed capsules and grape seed granulate for private customers as dietary supplements and for the cosmetic and pet care industries. Bioenergy Healthcare GmbH produces and markets nutritional medicine products for the dietary treatment of hepatic dysfunction, an elevated homocysteine level, age-related macular degeneration (AMD) and homocysteine-associated circulatory disorders.
| Last Annual | January 1st, 1970 |
| Last Interim | January 1st, 1970 |
| Public Since | December 27, 2012 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Financials |
| Industry | Investment Banking & Investment Services |
| Index | |
| Exchange | Munich Stock Exchange |
| Shares in Issue | |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | Franz-Marc-Str 4, KOELN, 50999, Germany |
| Web | http://www.bioenergy-capital.de/ |
| Phone | +49 221 139969840 |
| Contact | () |
As of 31/03/17, shares in Bioenergy Capital AG are trading at €0.27, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in Bioenergy Capital AG are currently trading at €0.27 and the price has moved by -81.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioenergy Capital AG price has moved by -82.2% over the past year.
There are no analysts currently covering Bioenergy Capital AG.
It is not known when Bioenergy Capital AG will next release financial results.
Bioenergy Capital AG does not currently pay a dividend.
Bioenergy Capital AG does not currently pay a dividend.
Bioenergy Capital AG does not currently pay a dividend.
To buy shares in Bioenergy Capital AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bioenergy Capital AG are currently trading at €0.27, giving the company a market capitalisation of £n/a.
Here are the trading details for Bioenergy Capital AG:
We were not able to load our ranking data for Bioenergy Capital AG
We were not able to load any forecast data for Bioenergy Capital AG.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioenergy Capital AG. Over the past six months, the relative strength of its shares against the market has been -74.36%. At the current price of €0.27, shares in Bioenergy Capital AG are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bioenergy Capital AG.
We were unable to find the directors for Bioenergy Capital AG.
Here are the top five shareholders of Bioenergy Capital AG based on the size of their shareholding:
